Qube Research & Technologies LTD 9 Meters Biopharma, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.21 - $0.32 $11,019 - $16,791	-52,473 Reduced 18.23%	235,334 $51,000
Q2 2022 Aug 15, 2022	BUY	$0.26 - $0.64 $74,829 - $184,196	287,807 New	287,807 $75,000
Q3 2021 Nov 12, 2021	SELL	$1.03 - $1.41 $282,904 - $387,277	-274,665 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.04 - $1.5 $60,806 - $87,702	58,468 Added 27.04%	274,665 $302,000
Q1 2021 May 14, 2021	BUY	$0.84 - $2.16 $136,542 - $351,108	162,550 Added 303.0%	216,197 $253,000
Q4 2020 Feb 16, 2021	SELL	$0.65 - $1.11 $116,090 - $198,247	-178,601 Reduced 76.9%	53,647 $46,000
Q3 2020 Nov 12, 2020	BUY	$0.48 - $0.84 $86,176 - $150,809	179,535 Added 340.59%	232,248 $189,000
Q2 2020 Aug 14, 2020	BUY	$0.43 - $0.74 $22,666 - $39,007	52,713 New	52,713 $30,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.